Karen Sánchez Trejo

Karen Sánchez Trejo

Auto-generated profile, based on publicly available information

Karen Sánchez Trejo

Departamento de Evaluación Económica, Agencia Mexicana de Evaluación de Tecnologías Sanitarias AC, Cerrada Gavilán #68 int 2 Col Barrio San Miguel, Iztapalapa, CP 09360, Mexico City, Mexico

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2021 in Journal of Comparative Effectiveness Research
Verified
Journal Article
Closed access
HGHumberto Garcia-Aguilar
Humberto Garcia-Aguilar
SVSilvia Guzmán Vázquez
Silvia Guzmán Vázquez
KTKaren Sánchez Trejo
Karen Sánchez Trejo
YJYazmin Escobar Juárez
Yazmin Escobar Juárez
KVKatiria Itzel Juárez Vásquez
Katiria Itzel Juárez Vásquez
HMHerman Soto Molina
Herman Soto Molina
Aim: The objective of this study was to evaluate the healthcare costs and resource utilization of pediatric pulmonary arterial hypertension management at a third-level hospital in Mexico. Methods: A retrospective cohort study was conducted in a pediatric population with pulmonary arterial hypertension. Only direct medical costs, derived from pharmacological treatment, laboratory tests, physician visits and hospitalizations, were considered. From an institutional perspective, all costs were accounted for in 2019 US dollars. Results: A total of 82 patients were included. Of these, 55% were female and the mean age was 6.9 (standard deviation ± 4) years. The mean annual cost was $17,452.14 (standard deviation ± $38,944.10), with a median cost of $8832.75. Conclusion: Pulmonary arterial hypertension is a costly disease, with hospitalization and pharmacological treatment being areas with a higher economic burden. Functional class IV has greater resource utilization and costs.